Harvard |

Harvard

Matches in Harvard for { <http://id.lib.harvard.edu/aleph/009116295/catalog> ?p ?o. }

Showing items 1 to 42 of 42 with 100 items per page.

catalog alternative "At head of cover title: Progress and controversies in oncological urology VII (PACIOU VII)".
catalog alternative "At head of cover title: Seventh congress of the Dutch Urological Association".
catalog contributor b12840030.
catalog contributor b12840031.
catalog contributor b12840032.
catalog contributor b12840033.
catalog contributor b12840034.
catalog created "2003.".
catalog date "2003".
catalog date "2003.".
catalog dateCopyrighted "2003.".
catalog description "Ch. 1. Sexual health in the aging male -- Ch. 2. Determinants of sexual function in the aging male -- Ch. 3. Impact of radical prostatectomy and primary radiotherapy for localized prostate cancer on quality of life -- Ch. 4. Sexual function before and after radical retropubic prostatectomy: a prospective analysis -- Ch. 5. Effects of endocrine treatment: can libido and sexual function be preserved? -- Ch. 6. Oral therapy -- Ch. 7. Intracavernosal injection therapy for erectile dysfunction: an update -- Ch. 8. Mechanisms and prevention of erectile dysfunction after radiotherapy for prostate cancer -- Ch. 9. Evaluation and management of lower urinary tract symptoms related to benign prostate disease: the contribution of the International Continence Society -- 'Benign Prostatic Hyperplasia' study -- Ch. 10. Distinguishing nocturnal polyuria from benign prostatic hyperplasia-related nocturia: simple algorithms for general and urological practice -- ".
catalog description "Ch. 11. Practical application of non-invasive tests to grade outflow obstruction and bladder contractility: the end of classical urodynamics? -- Ch. 12. Screening for prostate cancer within the benign prostatic hypertrophy population: current evidence and future directions -- Ch. 13. Androgens supplementation in older men: what is the impact on prostate-specific antigen, prostate growth and lower urinary tract symptoms? -- Ch. 14. Diagnosis, classification and therapy development for human prostate cancer using biochip technologies and post-genomic era molecular medicine -- Ch. 15. Candidate genetic markers and therapeutic targets in hereditary and sporadic prostate cancer -- Ch. 16. Basic research on prostate cancer: signal transduction -- Ch. 17. Stem cells and differentiation in human prostate cancer -- Ch. 18. Role of the stromal microenvironment in carcinogenesis of the prostate -- Ch. 19. Prostate cancer xenograft models -- Ch. 20. Hormonal regulation of prostate cancer -- ".
catalog description "Ch. 21. Profiling protein interactions in angiogenesis -- Ch. 22. The immunotherapy of prostate cancer -- Ch. 23. Prognostic tissue factors for prostate cancer: recent developments and pitfalls -- Ch. 24. Diagnostic markers for prostate cancer detected in serum, plasma or blood: prostate-specific antigen forms and human kallikrein 2 for early detection and staging -- Ch. 25. Expected impact of new technologies on prostate cancer research.".
catalog description "Ch. 26. Predictive algorithms and their clinical relevance -- Ch. 27. Defining the proper 'window' of opportunity' in the early detection of prostate cancer -- Ch. 28. Screening for prostate cancer: views from the UK and the rest of the world -- Ch. 29. Outcome after radical prostatectomy: how predictive are biopsies versus radical prostatectomy specimens? -- Ch. 30. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer -- Ch. 31. Prostate cancer mortality and screening -- Ch. 32. Expectant management with selective delayed intervention for favorable-risk prostate cancer -- Ch. 33. Is cure of prostate cancer possible in those in whom it is necessary? -- Ch. 34. Modern molecular classification of renal cell carcinoma: relevance for urologists -- Ch. 35. Prognostic factors for renal cell carcinoma -- Ch. 36. High-tech diagnostic procedures in renal cell carcinoma: promise practice -- Ch. 37. Technical and surgical progress in organ-sparing approaches for renal cell carcinoma -- Ch. 38. Surgery for renal cell carcinoma: the case for open surgery -- Ch. 39. Laparoscopic partial nephrectomy -- Ch. 40. Laparoscopic radical nephrectomy -- Ch. 41. Clinical research avenues in metastatic renal cell carcinoma -- Ch. 42. Diet and prostate cancer -- Ch. 43. Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer -- Ch. 44. Use of adjuvant hormonal therapy with radical prostatectomy in lymph node-positive disease: rationale and contribution to outcome -- Ch. 45. Side-effects of endocrine treatment: role of duration of treatment -- Ch. 46. Chemotherapy for the treatment of hormone-refractory prostate cancer: evaluating new targets based on apoptotic pathways -- Ch. 47. The role of bisphosphonates in prostate cancer -- Ch. 48. Direct from the pipeline: results of phase I and II studies of new drugs -- Ch. 49. Chemotherapy in the management of prostate cancer".
catalog description "Includes bibliographical references and index.".
catalog extent "xii, 444 p. :".
catalog identifier "1842141961 (alk. paper)".
catalog issued "2003".
catalog issued "2003.".
catalog language "eng".
catalog publisher "Boca Raton : Parthenon Pub. Group,".
catalog subject "2003 F-751".
catalog subject "616.99/463 21".
catalog subject "Benign prostatic hyperplasia Congresses.".
catalog subject "Erectile Dysfunction".
catalog subject "Impotence Congresses.".
catalog subject "Kidneys Cancer Congresses.".
catalog subject "Prostate Cancer Congresses.".
catalog subject "Prostatic Hyperplasia".
catalog subject "Prostatic Neoplasms".
catalog subject "RC280.P7 C66 2002".
catalog subject "WJ 752 C749p 2003".
catalog tableOfContents "Ch. 1. Sexual health in the aging male -- Ch. 2. Determinants of sexual function in the aging male -- Ch. 3. Impact of radical prostatectomy and primary radiotherapy for localized prostate cancer on quality of life -- Ch. 4. Sexual function before and after radical retropubic prostatectomy: a prospective analysis -- Ch. 5. Effects of endocrine treatment: can libido and sexual function be preserved? -- Ch. 6. Oral therapy -- Ch. 7. Intracavernosal injection therapy for erectile dysfunction: an update -- Ch. 8. Mechanisms and prevention of erectile dysfunction after radiotherapy for prostate cancer -- Ch. 9. Evaluation and management of lower urinary tract symptoms related to benign prostate disease: the contribution of the International Continence Society -- 'Benign Prostatic Hyperplasia' study -- Ch. 10. Distinguishing nocturnal polyuria from benign prostatic hyperplasia-related nocturia: simple algorithms for general and urological practice -- ".
catalog tableOfContents "Ch. 11. Practical application of non-invasive tests to grade outflow obstruction and bladder contractility: the end of classical urodynamics? -- Ch. 12. Screening for prostate cancer within the benign prostatic hypertrophy population: current evidence and future directions -- Ch. 13. Androgens supplementation in older men: what is the impact on prostate-specific antigen, prostate growth and lower urinary tract symptoms? -- Ch. 14. Diagnosis, classification and therapy development for human prostate cancer using biochip technologies and post-genomic era molecular medicine -- Ch. 15. Candidate genetic markers and therapeutic targets in hereditary and sporadic prostate cancer -- Ch. 16. Basic research on prostate cancer: signal transduction -- Ch. 17. Stem cells and differentiation in human prostate cancer -- Ch. 18. Role of the stromal microenvironment in carcinogenesis of the prostate -- Ch. 19. Prostate cancer xenograft models -- Ch. 20. Hormonal regulation of prostate cancer -- ".
catalog tableOfContents "Ch. 21. Profiling protein interactions in angiogenesis -- Ch. 22. The immunotherapy of prostate cancer -- Ch. 23. Prognostic tissue factors for prostate cancer: recent developments and pitfalls -- Ch. 24. Diagnostic markers for prostate cancer detected in serum, plasma or blood: prostate-specific antigen forms and human kallikrein 2 for early detection and staging -- Ch. 25. Expected impact of new technologies on prostate cancer research.".
catalog tableOfContents "Ch. 26. Predictive algorithms and their clinical relevance -- Ch. 27. Defining the proper 'window' of opportunity' in the early detection of prostate cancer -- Ch. 28. Screening for prostate cancer: views from the UK and the rest of the world -- Ch. 29. Outcome after radical prostatectomy: how predictive are biopsies versus radical prostatectomy specimens? -- Ch. 30. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer -- Ch. 31. Prostate cancer mortality and screening -- Ch. 32. Expectant management with selective delayed intervention for favorable-risk prostate cancer -- Ch. 33. Is cure of prostate cancer possible in those in whom it is necessary? -- Ch. 34. Modern molecular classification of renal cell carcinoma: relevance for urologists -- Ch. 35. Prognostic factors for renal cell carcinoma -- Ch. 36. High-tech diagnostic procedures in renal cell carcinoma: promise practice -- Ch. 37. Technical and surgical progress in organ-sparing approaches for renal cell carcinoma -- Ch. 38. Surgery for renal cell carcinoma: the case for open surgery -- Ch. 39. Laparoscopic partial nephrectomy -- Ch. 40. Laparoscopic radical nephrectomy -- Ch. 41. Clinical research avenues in metastatic renal cell carcinoma -- Ch. 42. Diet and prostate cancer -- Ch. 43. Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer -- Ch. 44. Use of adjuvant hormonal therapy with radical prostatectomy in lymph node-positive disease: rationale and contribution to outcome -- Ch. 45. Side-effects of endocrine treatment: role of duration of treatment -- Ch. 46. Chemotherapy for the treatment of hormone-refractory prostate cancer: evaluating new targets based on apoptotic pathways -- Ch. 47. The role of bisphosphonates in prostate cancer -- Ch. 48. Direct from the pipeline: results of phase I and II studies of new drugs -- Ch. 49. Chemotherapy in the management of prostate cancer".
catalog title "At head of cover title: Progress and controversies in oncological urology VII (PACIOU VII)".
catalog title "At head of cover title: Seventh congress of the Dutch Urological Association".
catalog title "Prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research : an update : the proceedings of the VII Congress on Progress and Controversies in Oncological Urology (PACIOU VII) and the Seventh Congress of the Dutch Urological Association, Rotterdam, The Netherlands, October 2002 / edited by Ch.H. Bangma and D.W.W. Newling ; co-editors, J.L.H.R. Bosch ... [et al.].".
catalog type "Congresses".
catalog type "text".